ReviewFrontiers in oncology2026

Minimal residual disease in cervical cancer: biological persistence, ctHPV DNA-guided surveillance, and recurrence-directed intervention.

Jing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.